ReviewOncoTargets and therapy2022

Targeted Therapy for Relapsed/Refractory Follicular Lymphoma: Focus on Clinical Utility of Tazemetostat.

Ruben Raychaudhuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.